As a top Brit Medical Officer sounds the alarm on swine flu, pharmaceutical companies, face-mask manufacturers and internet opportunists are cashing in on the mass hysteria surrounding the pandemic.
Sir Liam Donaldson, the Chief Medical Officer for England, had warned last week that the outbreak is confronting the NHS with its "biggest challenge in a generation."
The disease's explosive global advance has sent everyone from private citizens to national governments on a mass shopping spree to try to buy cures.
Swine Flu might not be a funny disease but GlaxoSmithKline, the British drugs company producing most of the country's swine flu vaccine, is laughing all the way to the bank.
As it moved to become the pharmaceutical group with the broadest range of products to tackle the pandemic, last week unveiling plans to sell masks and diagnostic kits to test for the disease as well as vaccines and antiviral medicines, industry analysts estimated GSK could make up to one billion pounds from sales of its swine flu vaccine alone.
It already has orders for 195 million doses, which may cost six pound a dose in the UK, from 16 governments around the world.
"We are trying to strike a balance between society and our shareholders, who want to see a return on the risks we take," GSK's CEO Andrew Witty said.
With up to one in three of the population estimated to be at risk of falling ill - and up to 65,000 of those actually dying - the Government has been left with little choice but to dig deep to try to limit the fallout.